Read more
April 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…
Read more
April 2023
Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April…
Read more
April 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…
Read more
March 2023
In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more…
Read more
March 2023
JACC Review Topic of the Week. In this review the authors aim to summarize the role of PCAT in cardiac…
Read more
March 2023
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
Read more
March 2023
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…
Read more
February 2023
Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…
Get in touch for more information.
